====== Asunaprenir 3μM R07 exp336 ====== ==== Mechanism of Action ==== Block the enzymatic activity of the HCV NS3 protease * **Class / Subclass 1:** Infectious Disease / Antiviral * **Class / Subclass 2:** Proteostasis / Protease Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%Asunaprevir%% * **Synonyms:** BMS-650032 * **CAS #:** 630420-16-5 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/16076883|16076883]] * **IUPAC:** %%tert-butyl N-[(2S)-1-[(2S,4R)-4-(7-chloro-4-methoxyisoquinolin-1-yl)oxy-2-[[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate%% * **INCHI Name:** InChI=1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1 * **INCHI Key:** XRWSZZJLZRKHHD-WVWIJVSJSA-N * **Molecular Weight:** 748.3 * **Canonical SMILES:** CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C * **Isomeric SMILES:** CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C * **Molecular Formula:** C35H46ClN5O9S {{:chemogenomics:structures:chem-0194.svg?nolink}} * **Supplier Name:** Cayman Chemical * **Catalog #:** 20835 * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C35H46ClN5O9S 748.27775; found 748.2781 * **Platform ID:** Asunaprenir * **Min:** -14.1488; **Max:** 71.6111 {{:chemogenomics:dose_response:dr_372.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |8.1460 | | IC30 |9.5861 | | IC40 |11.3074 | | IC50 |13.6671 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 07 * **Dose**: 3µM * **Days of incubation**: 8 * **Doublings**: 6.8 * **Numbers of reads**: 23139465 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |2/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Asunaprenir_3uM_Round-7_exp336.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp336.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:K:KDSR|KDSR]]|-3.42|<0.01| |[[:human_genes:D:DPAGT1|DPAGT1]]|-3.41|<0.01| |[[:human_genes:C:CDIPT|CDIPT]]|-2.93|0.17| |[[:human_genes:D:DKC1|DKC1]]|-2.57|0.67| |[[:human_genes:E:EPAS1|EPAS1]]|-2.46|0.22| |[[:human_genes:Z:ZMYM2|ZMYM2]]|-2.44|0.17| |[[:human_genes:V:VEZT|VEZT]]|-2.21|0.35| |[[:human_genes:M:MRPL33|MRPL33]]|-2.19|0.75| |[[:human_genes:Z:ZNF267|ZNF267]]|-2.14|0.44| |[[:human_genes:O:OSGEP|OSGEP]]|-2.10|0.54| |[[:human_genes:R:RPE|RPE]]|-2.08|0.54| |[[:human_genes:T:TXNL4B|TXNL4B]]|-2.06|0.54| |[[:human_genes:R:RESP18|RESP18]]|-2.02|0.54| |[[:human_genes:B:BGLAP|BGLAP]]|-2.00|0.54| |[[:human_genes:Z:ZNF561|ZNF561]]|-2.00|0.54| |[[:human_genes:S:SALL1|SALL1]]|-1.99|0.54| |[[:human_genes:V:VPS37B|VPS37B]]|-1.98|0.54| |[[:human_genes:K:KBTBD13|KBTBD13]]|-1.97|0.54| |[[:human_genes:L:LOC286238|LOC286238]]|-1.96|0.54| |[[:human_genes:W:WDR7|WDR7]]|-1.95|0.54| |[[:human_genes:R:RCE1|RCE1]]|-1.93|0.54| |[[:human_genes:T:TRIAP1|TRIAP1]]|-1.92|0.56| |[[:human_genes:I:IL22RA2|IL22RA2]]|-1.91|0.54| |[[:human_genes:B:BCAS3|BCAS3]]|-1.91|0.54| |[[:human_genes:A:ALG5|ALG5]]|-1.89|0.54| |[[:human_genes:I:IWS1|IWS1]]|-1.89|0.54| |[[:human_genes:S:SUGT1|SUGT1]]|-1.87|0.54| |[[:human_genes:R:RIBC1|RIBC1]]|-1.87|0.75| |[[:human_genes:H:HN1L|HN1L]]|-1.86|0.54| |[[:human_genes:T:TRIM13|TRIM13]]|-1.86|0.54| |[[:human_genes:K:KPNB1|KPNB1]]|1.88|0.76| |[[:human_genes:C:CYTIP|CYTIP]]|1.88|0.63| |[[:human_genes:C:CTBP1|CTBP1]]|1.89|0.63| |[[:human_genes:R:RPL7L1|RPL7L1]]|1.89|0.73| |[[:human_genes:U:USP17L19|USP17L19]]|1.96|0.74| |[[:human_genes:H:HK2|HK2]]|1.97|0.73| |[[:human_genes:F:F12|F12]]|1.97|0.73| |[[:human_genes:C:CCDC94|CCDC94]]|1.99|0.73| |[[:human_genes:P:PCDHGB3|PCDHGB3]]|2.00|0.63| |[[:human_genes:E:EPS8L3|EPS8L3]]|2.02|0.63| |[[:human_genes:C:C19orf38|C19orf38]]|2.07|0.49| |[[:human_genes:N:NKTR|NKTR]]|2.07|0.73| |[[:human_genes:C:CLEC11A|CLEC11A]]|2.08|0.73| |[[:human_genes:T:TRIM23|TRIM23]]|2.09|0.48| |[[:human_genes:M:MTMR1|MTMR1]]|2.09|0.48| |[[:human_genes:L:LRRC30|LRRC30]]|2.10|0.55| |[[:human_genes:P:PANX3|PANX3]]|2.11|0.55| |[[:human_genes:O:OR6K2|OR6K2]]|2.13|0.63| |[[:human_genes:R:RPL17|RPL17]]|2.14|0.55| |[[:human_genes:M:MRM1|MRM1]]|2.14|0.46| |[[:human_genes:R:RPS3A|RPS3A]]|2.15|0.63| |[[:human_genes:E:EIF3D|EIF3D]]|2.15|0.55| |[[:human_genes:C:CKAP5|CKAP5]]|2.16|0.73| |[[:human_genes:H:HIST1H2BI|HIST1H2BI]]|2.23|0.37| |[[:human_genes:L:LRRC4C|LRRC4C]]|2.27|0.37| |[[:human_genes:F:FTSJ3|FTSJ3]]|2.32|0.37| |[[:human_genes:P:PLRG1|PLRG1]]|2.34|0.37| |[[:human_genes:N:NLRP14|NLRP14]]|2.35|0.37| |[[:human_genes:P:PLEKHS1|PLEKHS1]]|2.44|0.37| |[[:human_genes:R:RPSA|RPSA]]|2.89|0.55| ^Screen^Correlation^Plot^ |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|0.059|| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|0.053|| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|0.053|| |[[:results:exp358|FK-506 5μM R07 exp358]]|0.051|| {{:chemogenomics:comparison_plots:exp336_vs_exp393.png?nolink |}} {{:chemogenomics:comparison_plots:exp336_vs_exp341.png?nolink |}} {{:chemogenomics:comparison_plots:exp336_vs_exp375.png?nolink |}} {{:chemogenomics:comparison_plots:exp336_vs_exp358.png?nolink |}} No GO term hits below threshold. (FDR <0.05) No GO term hits below threshold. (FDR <0.05)